| Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
|---|
| 07/29/2004 | WO2004043336A3 Methods of using and compositions comprising selective cytokine inhibitory drugs for the treatment and management of myeloproliferative diseases |
| 07/29/2004 | WO2004003032A3 Heterocyclic nitrogen-containing activators and catalyst systems for olefin polymerization |
| 07/29/2004 | WO2003101382A3 Compounds useful in the treatment of anthrax and inhibiting lethal factor |
| 07/29/2004 | WO2003092622A3 Carvedilol monocitrate monohydrate |
| 07/29/2004 | US20040147759 Enzyme inhibitors as antiinflammatory agents or muscle relaxants |
| 07/29/2004 | US20040147752 Carbazole derivatives for the treatment of NPY related diseases |
| 07/29/2004 | US20040147746 Such as N-{2-[2-(5-Bromo-2-methoxy-phenyl)-ethyl]-3-fluoro-benzoyl}-N'-butyl-guanidine; involuntary weight loss disorders |
| 07/29/2004 | US20040147745 Novel compounds and compositions as protease inhibitors |
| 07/29/2004 | US20040147741 Heptadecapeptide nociceptin opioid receptor modulators; pain relievers; synthesis |
| 07/29/2004 | US20040147607 Storage stability |
| 07/29/2004 | US20040147589 Indolone derivatives having vascular damaging activity |
| 07/29/2004 | US20040147588 Phosphodiesterase inhibitor; tumor necrosis factor antagonist; autoimmune diseases; sepsis; malaria ; skin disorders; anticancer agents; antiarthritic agents; Crohn's disease; inflammatory bowel disorders |
| 07/29/2004 | US20040147587 Compounds for the modulation of the glycolysis enzyme and/or transaminase complex |
| 07/29/2004 | US20040147586 Antiproliferative agents; anticancer agents; glioblastomas; antidiabetic agents; autoimmune disorders; skin disorders; antiarthritic agents; antiinflammatory agents; cardiovascular disorders |
| 07/29/2004 | US20040147584 1,3-diarylprop-2-en-1-ones, compositions containing them and use thereof |
| 07/29/2004 | US20040147538 Fused heterocyclic compounds |
| 07/29/2004 | US20040147503 Antiarthritic agents; muscular dystrophy; antiinflammatory agents; antitumor agents; glomerulonephritis |
| 07/29/2004 | US20040146746 Diphenyl anthracene derivatives and organic electroluminescent device employing the same |
| 07/29/2004 | US20040146554 Providing an active pharmaceutical compound; providing a basic salt as one of a powder, a suspension and a solution having a pH greater than 7; combining; delivering the non-enteric coated liquid formulation |
| 07/29/2004 | DE10302020A1 New beta-isoindigo compounds, useful as pigments or dyes in e.g. toners, lacquers, plastics or inks, are obtained by condensation of a bis-isoindolidene-diimine with an alicyclic or heterocyclic compound |
| 07/29/2004 | DE10301804A1 New 6-alkyl-2,4-dihalophenyl-substituted tetramic acid derivatives, useful as herbicides and pesticides, especially insecticides, acaricides, nematocides, ectoparasiticides and antifouling agents |
| 07/29/2004 | CA2512257A1 1-propanol and 1-propylamine derivatives and their use as glucocorticoid ligands |
| 07/29/2004 | CA2510516A1 Fused heterocyclic derivatives as ppar modulators |
| 07/29/2004 | CA2509202A1 Fused heterocyclic derivatives as ppar modulators |
| 07/28/2004 | EP1440966A1 Indole derivatives useful for the treatment of diseases |
| 07/28/2004 | EP1440059A1 3-azabicyclo(3.1.0)hexane derivatives as opioid receptor antagonists |
| 07/28/2004 | EP1439834A1 Oxindole hydrazide modulators of protein tyrosine phosphatases (ptps) |
| 07/28/2004 | EP1439820A2 Methods and dosage forms for improving the bioavailability of therapeutic agents |
| 07/28/2004 | EP0931065B1 use of NITRIC ESTER DERIVATIVES IN the treatment of URINARY INCONTINENCE |
| 07/28/2004 | EP0927183B1 Spirocyclic metalloprotease inhibitors |
| 07/28/2004 | EP0823897B1 Nicotinic acid esters and pharmaceutical compositions containing them |
| 07/28/2004 | EP0823895B1 Fatty acid esters as bioactive compounds |
| 07/28/2004 | CN1516586A Novel oral general anesthetics and metabolitically resistant anticonvulsants |
| 07/28/2004 | CN1515673A Preparation method of antipode of (1R, 4S)-or (1S, 4R)-1-amino-4-(methylol)-2-cyclopentene derivative |
| 07/28/2004 | CN1515563A Aryl substituted piperazine for curing benign prostatauxe |
| 07/28/2004 | CN1515562A Phenyl-and aminophenyl-alkyl sulfonamide and urea derivative |
| 07/28/2004 | CN1515559A Phenyl-and aminophenyl-alkyl sulfonamide and urea derivative |
| 07/28/2004 | CN1515556A Intermediate compound for preparing aryl substituted piperazine |
| 07/28/2004 | CN1515555A Method for preparing 7-bromine quinolone carboxylic acid derivative or its salt |
| 07/28/2004 | CN1515552A Near infrared fluorescence contrast agent and fluorescence imaging |
| 07/28/2004 | CN1515551A 1,2-indane or indoline derivative |
| 07/28/2004 | CN1515548A Oxaminic acid used as thyroid gland receptor ligand and its derivative |
| 07/28/2004 | CN1159292C Aryl substitued cyclic amines as selective dopamine D3 ligands |
| 07/28/2004 | CN1159289C C-terminal modified oxamyl dipetides as inhibitors of the ICE/ced-3 family of cystenine proteases |
| 07/28/2004 | CN1159286C Preparation of 1-alkoxycarbonyl-3-phenylpropyl derivatives |
| 07/27/2004 | US6768024 Triamine derivative melanocortin receptor ligands and methods of using same |
| 07/27/2004 | CA2103861C Novel 7-(substituted)-8-(substituted-9-(substituted amino)-6-demethyl-6-deoxytetracyclines |
| 07/22/2004 | WO2004060882A1 Cb 1/cb 2 receptor ligands and their use in the treatment of pain |
| 07/22/2004 | WO2004060874A1 Imino acid derivatives for use as inhibitors of matrix metalloproteinases |
| 07/22/2004 | WO2004060873A1 Novel 5-hydroxyindole-3-carboxylate derivatives |
| 07/22/2004 | WO2004060872A1 Factor xa inhibitors |
| 07/22/2004 | WO2004060871A1 Indole-phenylsulfonamide derivatives used as ppar-delta activating compounds |
| 07/22/2004 | WO2004060313A2 Fluoroalkoxy-substituted 1, 3-dihydro-isoindolyl compounds and their pharmaceutical uses |
| 07/22/2004 | WO2004060308A2 Thiosemicarbazones as anti-virals and immunopotentiators |
| 07/22/2004 | WO2003087086A3 Substituted indoles |
| 07/22/2004 | WO2003044014A8 Indole-2-carboxamides as factor xa inhibitors |
| 07/22/2004 | US20040143125 Synthesis of dihalohydrins and tri- and tetra-substituted olefins |
| 07/22/2004 | US20040143123 zirconium complexes of bis(o-hydroxybenzylamines); further reaction of dicarbonyls such as methyl (2S)-5-chloro-2,3-dihydro-2-hydroxy-1-oxo-1H-indene-2-carboxylate with protected hydrazine and N-(XC(O))-N-methoxycarbonyl-p-(trifluoromethyl)aniline |
| 07/22/2004 | US20040143018 Thrombosis; emphysema; antihistamines; cirrhosis; antiarthritic agents; anticancer agenst |
| 07/22/2004 | US20040143016 Catalytic antioxidants and methods of use |
| 07/22/2004 | US20040143003 Cyclopropylindole derivatives as selective serotonin reuptake inhibitors |
| 07/22/2004 | US20040143002 Amorphous form of 3-[2-(dimethylamino) ethyl]-N-methyl-1H-indole-5-methane sulfonamide succinate (sumatriptan succinate) |
| 07/22/2004 | US20040142993 Viricides |
| 07/22/2004 | US20040142989 Viricides |
| 07/22/2004 | US20040142987 3-aminoalkyl-2-aryl-indole derivatives and their use as gnrh antagonists |
| 07/22/2004 | US20040142981 Sterilization, antiseptics for bacteria infections |
| 07/22/2004 | US20040142940 indole derivatives substituted by an amine at position 1, coupled to piperazine- or piperidine-type moieties anti-inflammatory agents |
| 07/22/2004 | US20040142933 treatment of schizophrenia and other central nervous system (CNS) disorders |
| 07/22/2004 | US20040142925 Piperazine derivatives their preparation and uses in therapy |
| 07/22/2004 | US20040142921 treatment and/or prevention of type 2 diabetes and associated metabolic syndrome |
| 07/22/2004 | US20040142206 substituted with aromatic groups, e.g., 2,2'-dihexyloxy-6,6'dianthracenyl- (or 6,6'-dipyrenyl-) 1,1'-binaphthylene; good solubility in common organic solvents, resist crystallization and can be sublimed in a device fabrication process. |
| 07/22/2004 | CA2512502A1 Indole-phenylsulfonamide derivatives used as ppar-delta activating compounds |
| 07/22/2004 | CA2512346A1 Imino acid derivatives for use as inhibitors of matrix metalloproteinases |
| 07/22/2004 | CA2511646A1 Thiosemicarbazones as anti-virals and immunopotentiators |
| 07/21/2004 | EP1439214A2 Fluorescent group-containing carbodiimide compound and process for producing the compound |
| 07/21/2004 | EP1439169A1 DIFLUOROALKENE DERIVATIVE, PEST CONTROL AGENT CONTAINING THE SAME, AND INTERMEDIATE THEREFOR |
| 07/21/2004 | EP1438290A1 Cyclohept b!indole derivatives as spla2 inhibitors |
| 07/21/2004 | EP1438289A1 Indole derivatives as cox ii inhibitors |
| 07/21/2004 | EP1438045A1 Use of indole and indoline derivatives in the treatment of obesity or for the reduction of food intake |
| 07/21/2004 | EP1438044A1 Bis-heteroaryl alkanes as therapeutic agents |
| 07/21/2004 | EP1147080B1 Alkynyl containing hydroxamic acid compounds as tace inhibitors |
| 07/21/2004 | EP1077694B1 Aryl nitrone therapeutics for the treatment of inflammatory bowel disease |
| 07/21/2004 | EP1051143B1 Oxidizing hair coloring agents containing 2,5-diamino-1-phenylbenzene derivatives and novel 2,5-diamino-1-phenylbenzene derivatives |
| 07/21/2004 | EP1047692B1 Methods of synthesizing and screening inhibitors of bacterial nad synthetase enzyme, compounds thereof and methods of treating bacterial and microbial infections with these inhibitors |
| 07/21/2004 | CN1514845A Oxime ester photoinitiatros having combined structure |
| 07/21/2004 | CN1514829A Novel herbicides |
| 07/21/2004 | CN1514714A Indole/indoline based hybird dyes and indole/indoline based hybrid dye intermediate products |
| 07/21/2004 | CN1158258C Alpha 1 beta-adrenergic receptor antagonists |
| 07/21/2004 | CN1158257C Novel amino pyrroline compound, its prepn. method and pharmaceutical compositions contg. same |
| 07/20/2004 | US6765099 Neo-tryptophan |
| 07/20/2004 | US6765023 Use of substituted N, N-disubstituted reverse aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
| 07/20/2004 | US6765021 Antidiabetic agents |
| 07/20/2004 | US6765014 1-Acyl-7-nitroindoline derivatives, their preparation and their use as photocleavable precursors |
| 07/20/2004 | US6765012 For modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation |
| 07/20/2004 | US6765008 Pyrrolopyrimidines as CRF antagonists |
| 07/20/2004 | CA2085555C Dual inhibitors of no synthase and cyclooxygenase, process for their preparation and therapeutical compositions containing them |
| 07/15/2004 | WO2004058911A2 Organic electroluminescent element |
| 07/15/2004 | WO2004058686A1 Hydroxypropyl amides for the treatment of alzheimer’s disease |
| 07/15/2004 | WO2004058174A2 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation |
| 07/15/2004 | WO2004058164A2 Asthma and allergic inflammation modulators |